Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

DXM Sales Age Restriction Reaches Florida; CHPA Navigates PSE Road

This article was originally published in The Tan Sheet

Executive Summary

Florida is the first of several states CHPA expects in 2016 will pass legislation banning sales of DXM-containing OTCs to minors. CHPA looks this year to support similar bills in Arkansas, Pennsylvania and Ohio while keeping an eye toward state activity on sales of PSE-containing OTCs.


Related Content

US Would Cough Up As Much As $31bn More For Rx-Only DXM Over 10 Years